Preclinical Imaging (In-VIVO) - Global Market Trajectory & Analytics

Description Table of
Contents Companies Mentioned

FEATURED COMPANIES

Aspect Imaging Ltd.
Idex Health & Science LLC
Mediso Ltd.
Miltenyi Biotech GmbH
New England Biolabs
Siemens A.G.
MORE

Global Preclinical Imaging (In-VIVO) Market to Reach $1.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Preclinical Imaging (In-VIVO) estimated at US$782.5 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at a CAGR of 4.8% over the period 2020-2027. Preclinical imaging modalities, one of the segments analyzed in the report, is projected to record 5.2% CAGR and reach US$681.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Preclinical imaging reagents segment is readjusted to a revised 4.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $230.5 Million, While China is Forecast to Grow at 4.5% CAGR

The Preclinical Imaging (In-VIVO) market in the U.S. is estimated at US$230.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$191.7 Million by the year 2027 trailing a CAGR of 4.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Select Competitors (Total 38 Featured):

Aspect Imaging Ltd.
Bruker Corp.
Idex Health & Science LLC
Mauna Kea Technologies
Mediso Ltd.
Milabs B.V.
Miltenyi Biotech GmbH
MR Solutions
New England Biolabs
PerkinElmer, Inc.
Siemens A.G.
Trifoil Imaging, Inc.
FujiFilm VisualSonics, Inc.

Frequently Asked Questions about the Global Market for Preclinical Imaging (In-VIVO)

What is the estimated value of the Global Market for Preclinical Imaging (In-VIVO)?

The Global Market for Preclinical Imaging (In-VIVO) was estimated to be valued at $782.5 Million in 2020.

What is the growth rate of the Global Market for Preclinical Imaging (In-VIVO)?

The growth rate of the Global Market for Preclinical Imaging (In-VIVO) is 5.0%, with an estimated value of $1100.0 Million by 2027.

What is the forecasted size of the Global Market for Preclinical Imaging (In-VIVO)?

The Global Market for Preclinical Imaging (In-VIVO) is estimated to be worth $1100.0 Million by 2027.

Who are the key companies in the Global Market for Preclinical Imaging (In-VIVO)?

Key companies in the Global Market for Preclinical Imaging (In-VIVO) include Aspect Imaging Ltd., Bruker Corp., Idex Health & Science LLC, Mauna Kea Technologies, Mediso Ltd., Milabs B.V., Miltenyi Biotech GmbH, MR Solutions and PerkinElmer, Inc..

Note: Product cover images may vary from those shown

FEATURED COMPANIES

Aspect Imaging Ltd.
Idex Health & Science LLC
Mediso Ltd.
Miltenyi Biotech GmbH
New England Biolabs
Siemens A.G.
MORE

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Current & Future Analysis for Preclinical Imaging (In-VIVO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
Table 2: World Historic Review for Preclinical Imaging (In-VIVO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Table 3: World 15-Year Perspective for Preclinical Imaging (In-VIVO) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2018 & 2027
Table 4: World Current & Future Analysis for Preclinical imaging modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
Table 5: World Historic Review for Preclinical imaging modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Table 6: World 15-Year Perspective for Preclinical imaging modalities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
Table 7: World Current & Future Analysis for Preclinical imaging reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
Table 8: World Historic Review for Preclinical imaging reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Table 9: World 15-Year Perspective for Preclinical imaging reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 10: USA Current & Future Analysis for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Table 11: USA Historic Review for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Table 12: USA 15-Year Perspective for Preclinical Imaging (In-VIVO) by Segment - Percentage Breakdown of Value Sales for Preclinical imaging modalities and Preclinical imaging reagents for the Years 2012, 2018 & 2027
CANADA
Table 13: Canada Current & Future Analysis for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Table 14: Canada Historic Review for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Table 15: Canada 15-Year Perspective for Preclinical Imaging (In-VIVO) by Segment - Percentage Breakdown of Value Sales for Preclinical imaging modalities and Preclinical imaging reagents for the Years 2012, 2018 & 2027
JAPAN
Table 16: Japan Current & Future Analysis for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Table 17: Japan Historic Review for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Table 18: Japan 15-Year Perspective for Preclinical Imaging (In-VIVO) by Segment - Percentage Breakdown of Value Sales for Preclinical imaging modalities and Preclinical imaging reagents for the Years 2012, 2018 & 2027
CHINA
Table 19: China Current & Future Analysis for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Table 20: China Historic Review for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Table 21: China 15-Year Perspective for Preclinical Imaging (In-VIVO) by Segment - Percentage Breakdown of Value Sales for Preclinical imaging modalities and Preclinical imaging reagents for the Years 2012, 2018 & 2027
EUROPE
Table 22: Europe Current & Future Analysis for Preclinical Imaging (In-VIVO) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR
Table 23: Europe Historic Review for Preclinical Imaging (In-VIVO) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Table 24: Europe 15-Year Perspective for Preclinical Imaging (In-VIVO) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2018 & 2027
Table 25: Europe Current & Future Analysis for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Table 26: Europe Historic Review for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Table 27: Europe 15-Year Perspective for Preclinical Imaging (In-VIVO) by Segment - Percentage Breakdown of Value Sales for Preclinical imaging modalities and Preclinical imaging reagents for the Years 2012, 2018 & 2027
FRANCE
Table 28: France Current & Future Analysis for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Table 29: France Historic Review for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Table 30: France 15-Year Perspective for Preclinical Imaging (In-VIVO) by Segment - Percentage Breakdown of Value Sales for Preclinical imaging modalities and Preclinical imaging reagents for the Years 2012, 2018 & 2027
GERMANY
Table 31: Germany Current & Future Analysis for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Table 32: Germany Historic Review for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Table 33: Germany 15-Year Perspective for Preclinical Imaging (In-VIVO) by Segment - Percentage Breakdown of Value Sales for Preclinical imaging modalities and Preclinical imaging reagents for the Years 2012, 2018 & 2027
ITALY
Table 34: Italy Current & Future Analysis for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Table 35: Italy Historic Review for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Table 36: Italy 15-Year Perspective for Preclinical Imaging (In-VIVO) by Segment - Percentage Breakdown of Value Sales for Preclinical imaging modalities and Preclinical imaging reagents for the Years 2012, 2018 & 2027
UNITED KINGDOM
Table 37: UK Current & Future Analysis for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Table 38: UK Historic Review for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Table 39: UK 15-Year Perspective for Preclinical Imaging (In-VIVO) by Segment - Percentage Breakdown of Value Sales for Preclinical imaging modalities and Preclinical imaging reagents for the Years 2012, 2018 & 2027
REST OF EUROPE
Table 40: Rest of Europe Current & Future Analysis for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Table 41: Rest of Europe Historic Review for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Table 42: Rest of Europe 15-Year Perspective for Preclinical Imaging (In-VIVO) by Segment - Percentage Breakdown of Value Sales for Preclinical imaging modalities and Preclinical imaging reagents for the Years 2012, 2018 & 2027
ASIA-PACIFIC
Table 43: Asia-Pacific Current & Future Analysis for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Table 44: Asia-Pacific Historic Review for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Table 45: Asia-Pacific 15-Year Perspective for Preclinical Imaging (In-VIVO) by Segment - Percentage Breakdown of Value Sales for Preclinical imaging modalities and Preclinical imaging reagents for the Years 2012, 2018 & 2027
REST OF WORLD
Table 46: Rest of World Current & Future Analysis for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR
Table 47: Rest of World Historic Review for Preclinical Imaging (In-VIVO) by Segment - Preclinical imaging modalities and Preclinical imaging reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR
Table 48: Rest of World 15-Year Perspective for Preclinical Imaging (In-VIVO) by Segment - Percentage Breakdown of Value Sales for Preclinical imaging modalities and Preclinical imaging reagents for the Years 2012, 2018 & 2027

IV. COMPETITION

Total Companies Profiled: 38

Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

Aspect Imaging Ltd.
Bruker Corp.
Idex Health & Science LLC
Mauna Kea Technologies
Mediso Ltd.
Milabs B.V.
Miltenyi Biotech GmbH
MR Solutions
New England Biolabs
PerkinElmer, Inc.
Siemens A.G.
Trifoil Imaging, Inc.
FujiFilm VisualSonics, Inc.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

What is the estimated value of the Global Market for Preclinical Imaging (In-VIVO)?

What is the growth rate of the Global Market for Preclinical Imaging (In-VIVO)?

What is the forecasted size of the Global Market for Preclinical Imaging (In-VIVO)?

Who are the key companies in the Global Market for Preclinical Imaging (In-VIVO)?

FEATURED COMPANIES

RELATED TAGS

RELATED PRODUCTS

Optical Preclinical Imaging Market by Modality and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030

Preclinical Imaging Market Research Report by Product (Modalities and Reagents), Application, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

Optical Preclinical Imaging Market Research Report by Product Type (Consumables, Device, and Software), End-use, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

Preclinical Imaging Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Preclinical Imaging Equipments Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type